DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Role of SNP and DIGOXIN Response in Atrial Fibrillation Patients

Information source: University of Monastir
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Atrial Fibrillation

Intervention: Digoxin (Drug)

Phase: N/A

Status: Recruiting

Sponsored by: University of Monastir

Official(s) and/or principal investigator(s):
Nouira Samir, Professor, Principal Investigator, Affiliation: University of Monastir

Overall contact:
Semir Nouira, Professor, Phone: +21673532014, Email: semir.nouira@rns.tn

Summary

This study tested the hypothesis that response to digoxin is modulated by single Nucleotid Polymorphism (SNP):

- Multi Drug Resistance (MDR1) gene haplotypes and Solute carrier organic anion

transporter family member 1B3 (SLCO1B3) gene Polymorphism and their role in the response to treatement.

- Aldosterone synthase (CYP11B2) gene and sodium channel, voltage-gated, type V alpha

subunit gene (SCN5A) correlated with atrial fibrillation and their roles in response to digoxin.

Clinical Details

Official title: Role of Genetic Factors in the Response to Digoxin in the Acute Treatment of Atrial Fibrillation

Study design: Observational Model: Case Control, Time Perspective: Prospective

Primary outcome: Correlation between the response to digoxin and the genotypes of the patients

Secondary outcome: Rhythm and Rate control

Detailed description: The frequency distribution of single nucleotide polymorphisms (SNPs) and haplotypes in the ABCB1 and SLCO1B3 genes varies largely among populations. The aim of this study is to investigate the genomic variations influence of these two genes on the response to digoxin in Tunisian atrial fibrillation (AF) patients. In fact human P-glycoprotein (P-gp) is encoded by the ABCB1 gene (MDR1), which is located on chromosomal region 7q21 and consists of 28 exons. To date, over 50 SNPs have been reported for this gene, some of them are known to be of functional relevance and can also alter the pharmacokinetics of substrate drugs. The aim of the current study is to analyze the ABCB1: C1236T (Gly412Gly), G2677>T⁄A (Ala893Ser/ Thr) and C3435T (Il1145Ile) polymorphisms. SLCO1B3 (OATP1B3) gene located on chromosomal region 12p12 is highly polymorphic. It is known to transport digoxin and expressed on the sinusoidal membranes of hepatocytes in humans. It mediated uptake into hepatocytes and may be an important step of the elimination of digoxin. In this study we will also investigate the relationship between two deletion polymorphisms (from -28 to -11 deletion) and (from-7 to -4 deletion), T334G (Ser112Ala) and G699A (Met233Ile) SNPs in the SLCO1B3gene and their role in response to digoxin. Another way, progress in understanding molecular mechanisms in AF supports the idea that variability in response to drug therapy may reflect differences in disease mechanisms, it is entirely possible that response to AF is highly heterogeneous because the arrhythmia itself is not a single pathophysiologic entity. Aldosterone synthase (CYP11B2) gene polymorphism was found to be correlated with atrial fibrillation (AF) risk. Moreover, the human cardiac sodium channel SCN5A is responsible for the fast depolarization upstroke of the cardiac action potential and serves as a molecular target for antiarrhythmic drugs. Mutations in the human cardiac sodium channel gene have been previously discovered in a spectrum of cardiac rhythm disorders. We hypothesized that the T-344C and H558R (His558Arg) SNPs in CYP11B2 and SCN5A gene which are associated with susceptibility to AF could be implicated in the variation of response to Digoxin.

Eligibility

Minimum age: 20 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Patients older than 20 years

- Quick AF (heart rate> 120 bpm) diagnosed by ECG

Exclusion Criteria:

- HR under 120 bpm

- Hemodynamically unstable patients

- Atrio-Ventricular-block (second or third degree)

- Ventricular rhythm disorder

- Acute coronary syndrome

- kidney failure

- Hypokalimia

Locations and Contacts

Semir Nouira, Professor, Phone: +21673532014, Email: semir.nouira@rns.tn

university of Monastir, Monastir 5000, Tunisia; Recruiting
Nouira Samir, Professor, Phone: 73532014, Ext: +216, Email: semir.nouira@rns.tn
Nouira Samir, Professor, Principal Investigator
Additional Information

official website

Starting date: July 2013
Last updated: June 16, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017